Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : antibody therapeutics
Nona Biosciences and Lonza Partner to Advance BBB Technology for CNS Therapies
07/02/2026 | Companies
antibody therapeutics,
BBB-crossing technology,
bioconjugation,
biologics development,
biologics discovery,
biotech partnership,
biotechnology collaboration,
blood-brain barrier,
CDMO services,
central nervous system diseases,
CNS disorders,
CNS drug development,
CNS therapeutics,
drug delivery technology,
drug manufacturing,
GlycoConnect technology,
GS Gene Expression System,
Harbour Mice platform,
HCAb technology,
Lonza,
neuroscience research,
next-generation therapeutics,
Nona Biosciences,
pharmaceutical innovation,
precision medicine,
protein development,
single-domain antibodies,
technology licensing,
therapeutic delivery,
VHH binders
Harbour BioMed Reports Positive Phase I Results for HBM9378 Antibody Therapy
03/23/2026 | Companies
antibody therapeutics,
biologics,
biotech innovation,
chronic obstructive pulmonary disease,
clinical research,
COPD,
drug development,
half-life extension,
Harbour BioMed,
HBM9378,
immune-oncology,
immunological disorders,
immunology,
Kelun-Biotech,
monoclonal antibody,
pharmacokinetics,
Phase I clinical trial,
respiratory medicine,
safety profile,
severe asthma,
SKB378,
TSLP inhibitor,
WIN378
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com